Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta
Osteoporosis International · 2024-07 · 35 (7) · 1303-1304
DOI: 10.1007/s00198-024-07089-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Osteoporosis International, online erschienen am 08.05.2024. Verfasst von Toru Kusakabe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical C…. Hauptthemen laut MEDLINE: Absorptiometry, Photon, Antibodies, Monoclonal, Bone Density, Bone Density Conservation Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan. kusakabe@kuhp.kyoto-u.ac.jp.
- Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan.
- Department of Endocrinology and Metabolism, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan.
- Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan.
ORCID-Profile: Toru Kusakabe
Zitieren
APA
Kusakabe, T., Ishihara, Y., Kitamura, T., Yasoda, A., Nanba, K., Tsuiki, M., Satoh-Asahara, N., & Tagami, T. (2024). Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta. Osteoporosis International, 35(7), 1303-1304. https://doi.org/10.1007/s00198-024-07089-2
Vancouver
Kusakabe T, Ishihara Y, Kitamura T, Yasoda A, Nanba K, Tsuiki M, et al. Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta. Osteoporosis International. 2024;35(7):1303-1304. doi:10.1007/s00198-024-07089-2
BibTeX
@article{Kusakabe2024,
author = {Kusakabe, Toru and Ishihara, Yuki and Kitamura, Takuya and Yasoda, Akihiro and Nanba, Kazutaka and Tsuiki, Mika and Satoh-Asahara, Noriko and Tagami, Tetsuya},
title = {Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta},
journal = {Osteoporosis International},
year = {2024},
volume = {35},
number = {7},
pages = {1303--1304},
doi = {10.1007/s00198-024-07089-2}
}
EUVIMED